MEIS1 and prostate adenocarcinoma: As shown in Figure 5a, the expressions of MEIS1 were different in various immune subtypes including C1-C6 in ACC, BLCA, BRCA, CHOL, COAD, KIRC, LGG, LUAD, LUSC, pancreatic adenocarcinoma (PAAD), PRAD, sarcoma (SARC), STAD, TGCT (all p < 0.05).